These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1959794)

  • 1. The epidemiology of ovarian cancer.
    Parazzini F; Franceschi S; La Vecchia C; Fasoli M
    Gynecol Oncol; 1991 Oct; 43(1):9-23. PubMed ID: 1959794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.
    Riman T; Persson I; Nilsson S
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):695-707. PubMed ID: 10209555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and gynecologic cancer: an update for the 1990s.
    Kaunitz AM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can breast cancer be prevented?].
    Vatten LJ
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1745-8. PubMed ID: 2063386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.
    Franceschi S; Parazzini F; Negri E; Booth M; La Vecchia C; Beral V; Tzonou A; Trichopoulos D
    Int J Cancer; 1991 Aug; 49(1):61-5. PubMed ID: 1874572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and ovarian cancer: an update, 1998-2004.
    La Vecchia C
    Eur J Cancer Prev; 2006 Apr; 15(2):117-24. PubMed ID: 16523008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of ovarian cancer.
    Tortolero-Luna G; Mitchell MF
    J Cell Biochem Suppl; 1995; 23():200-7. PubMed ID: 8747397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and risk assessment for ovarian cancer.
    Daly M; Obrams GI
    Semin Oncol; 1998 Jun; 25(3):255-64. PubMed ID: 9633839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause.
    Franceschi S; La Vecchia C; Booth M; Tzonou A; Negri E; Parazzini F; Trichopoulos D; Beral V
    Int J Cancer; 1991 Aug; 49(1):57-60. PubMed ID: 1874570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking and the risk of epithelial ovarian cancer.
    Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
    Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of ovarian cancer: a summary review.
    La Vecchia C
    Eur J Cancer Prev; 2001 Apr; 10(2):125-9. PubMed ID: 11330452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population attributable risk for ovarian cancer.
    Parazzini F; Chatenoud L; Chiantera V; Benzi G; Surace M; La Vecchia C
    Eur J Cancer; 2000 Mar; 36(4):520-4. PubMed ID: 10717530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
    Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
    BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer.
    Gross TP; Schlesselman JJ
    Obstet Gynecol; 1994 Mar; 83(3):419-24. PubMed ID: 8127536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives containing chlormadinone acetate and cancer incidence at selected sites in the German Democratic Republic--a correlation analysis.
    Nischan P; Ebeling K
    Int J Cancer; 1984 Nov; 34(5):671-4. PubMed ID: 6209226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.